Phase 2 Hepatitis B Virus Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited250 enrolled14 locationsNCT06650852
Recruiting
Phase 1Phase 2
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent
SCG Cell Therapy Pte. Ltd.46 enrolled6 locationsNCT05417932
Completed
Phase 2
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BW-20507 in Healthy Subjects
Chronic Hepatitis B Virus (HBV) Infection
Argo Biopharma Australia Pty Ltd32 enrolled3 locationsACTRN12623000709640
Active
Phase 2
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Subjects with Chronic Hepatitis B Virus (HBV) Infection
Chronic Hepatitis B Virus (HBV) Infection
Argo Biopharma Australia Pty Ltd32 enrolled3 locationsACTRN12623000708651
Active
Phase 2
An optional multicenter, open-label Phase 2a multiple dose study in Chronic Hepatitis B (CHB) subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778
Chronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc.24 enrolled6 locationsACTRN12623000111673
Recruiting
Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Subjects with Chronic HBV Infection (CHB) and Chronic HDV Infection (CHD).
Chronic Hepatitis D Virus (HDV) InfectionChronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc.72 enrolled9 locationsACTRN12623000105640